New Delhi, April 22 (RHC)-- In India, Mumbai health officials say they will administer hydroxychloroquine to thousands of residents to test the drug’s potential as a preventative treatment for the coronavirus. 

The anti-malarial drug repeatedly touted by Trump will reportedly be tested in Dharavi, one of Asia’s largest slums, as well as in Worli, the Mumbai neighborhood hardest hit by the virus. 

Critics are calling out the move to test the unproven and potentially dangerous drug on some of the city’s poorest residents. 

In other news from Mumbai, at least 200 healthcare professionals have tested positive for COVID-19.  India has reported around 16,000 confirmed cases and 500 deaths, but true numbers are likely much higher.